tiprankstipranks
Landos Biopharma (LABP)
NASDAQ:LABP
US Market
Holding LABP?
Track your performance easily

Landos Biopharma (LABP) Financial Statements

117 Followers

Landos Biopharma Financial Overview

Landos Biopharma's market cap is currently ―. The company's EPS TTM is $-3.994; its P/E ratio is -5.74; Landos Biopharma is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue----$ 0.00
Gross Profit-----
EBIT$ -6.52M$ -3.92M$ -6.48M$ -7.78M$ -7.83M
EBITDA$ -6.52M$ -3.91M$ -6.45M$ -7.68M$ -7.83M
Net Income Common Stockholders$ -5.86M$ -3.92M$ -5.90M$ -5.16M$ -7.90M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 42.47M$ 44.74M$ 50.01M$ 44.40M$ 47.99M
Total Assets$ 43.23M$ 46.28M$ 51.18M$ 45.25M$ 49.49M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -42.47M$ -44.74M$ -50.01M$ -44.40M$ -47.99M
Total Liabilities$ 5.57M$ 3.02M$ 4.16M$ 6.12M$ 5.47M
Stockholders Equity$ 37.71M$ 43.25M$ 46.98M$ 39.16M$ 44.01M
Cash Flow-
Free Cash Flow$ -2.23M$ -5.11M$ -8.17M$ -3.64M$ -7.57M
Operating Cash Flow$ -2.23M$ -5.11M$ -8.17M$ -3.70M$ -7.57M
Investing Cash Flow$ 634.00K$ 3.97M$ 3.10M$ 11.47M$ 17.21M
Financing Cash Flow-$ -99.00K$ 13.67M-$ 0.00
Currency in USD

Landos Biopharma Earnings and Revenue History

Landos Biopharma Debt to Assets

Landos Biopharma Cash Flow

Landos Biopharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis